| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.041 | 0.1 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.2 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |